한글목차

중심 정맥 카테터(CVC) 세계 시장은 2030년까지 20억 달러에 이를 전망

2023년에 13억 달러로 추정되는 중심 정맥 카테터(CVC) 세계 시장은 분석 기간인 2023-2030년에 CAGR 6.1%로 성장하여 2030년에는 20억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 멀티 루멘 CVC는 CAGR 6.8%를 나타내고, 분석 기간 종료시에는 9억 7,140만 달러에 이를 것으로 예측됩니다. 트리플 루멘 CVC 부문의 성장률은 분석 기간에 CAGR 5.7%로 추정됩니다.

미국 시장은 4억 4,000만 달러, 중국은 CAGR 7.7%로 성장 예측

미국의 중심 정맥 카테터(CVC) 시장은 2023년에 4억 4,000만 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 2억 4,080만 달러 규모에 이를 것으로 예측되며, 분석 기간인 2023-2030년간 CAGR은 7.7%를 나타낼 전망입니다. 기타 주목해야 할 지역별 시장으로서는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 5.0%와 5.1%를 나타낼 것으로 예측됩니다. 유럽에서는 독일이 CAGR 5.5%를 나타낼 전망입니다.

세계 중심 정맥 카테터(CVC) 시장 - 주요 동향 및 촉진요인 요약

중심정맥카테터(CVC)는 투약, 수액, 혈액제제, 비경구영양제, 혈액투석, 중심정맥압 모니터링 등에 사용되는 중요한 의료장비입니다. CVC는 일반적으로 경부(내경정맥), 흉부(쇄골하정맥), 살서제(대퇴정맥)와 같은 굵직한 정맥에 삽입되어 심장에 가까운 중심정맥으로 연결되며, CVC는 중증 환자, 대수술 환자, 장기적인 정맥주입이 필요한 환자 관리에 필수적이며, CVC는 생명을 구하는 치료의 시행과 정확한 혈역학 평가에 필수적입니다. 정확한 혈역학 평가에 필수적인 신뢰할 수 있는 장기적인 정맥 접근점을 제공합니다.

CVC 기술의 발전으로 안전성, 유효성 및 사용 편의성이 크게 향상되었습니다. 최신 CVC는 감염 및 기계적 합병증의 위험을 최소화하는 기능을 갖추고 있습니다. 예를 들어, 항균 코팅 카테터는 임상 현장에서 큰 문제가 되고 있는 카테터 관련 혈류 감염(CRBSI)의 발생률을 낮추기 위해 개발되었습니다. 또한, 카테터 소재와 삽입 기술의 발전으로 CVC의 내구성과 생체적합성이 향상되고 있습니다. 카테터 삽입에 초음파 가이드를 사용하는 것이 표준이 되어 삽입과 관련된 합병증이 크게 감소하고 시술 성공률이 향상되었습니다. 이러한 기술적, 시술적 혁신으로 CVC는 환자와 의료진 모두에게 더욱 안전하고 신뢰할 수 있는 시술이 되었습니다.

중심정맥카테터 시장의 성장은 만성질환의 유병률 증가, 의료기술의 발전, 수술 건수 증가 등 여러 가지 요인에 기인합니다. 전 세계적으로 암, 신장 질환, 심부전 등 만성 질환이 증가함에 따라 장기적인 정맥 내 치료에 대한 수요가 증가하여 CVC의 필요성이 증가하고 있습니다. 기술의 발전으로 보다 진보되고 안전한 CVC가 개발되어 임상 현장에서의 채택이 증가하고 있습니다. 또한, 외과 수술 증가와 집중 치료가 필요한 노인 인구 증가는 시장 성장을 더욱 촉진하고 있습니다. 감염 예방에 대한 관심 증가와 CVC용 항균 및 항혈전 코팅 시장 개척도 시장 확대에 기여하고 있습니다. 이러한 요인들은 카테터 설계 및 기능 개선을 위한 지속적인 연구개발 노력과 함께 중심정맥카테터 시장의 견조한 성장을 견인하고 있습니다.

조사 대상 기업 예(총 61건)

• GE Healthcare
• ConMed Corporation
• Edwards Lifesciences Corporation
• Biosensors International Group Ltd.
• ICU Medical, Inc.
• FUJIFILM SonoSite, Inc.
• Biometrix BV
• Bactiguard
• Global Medikit Ltd.
• Comed B.V.
• Foshan Special Medical Co., Ltd.
• Guangdong Baihe Medical Technology Co., Ltd.
• Biotronix Healthcare, Inc.
• Bionic Medizintechnik GmbH
• HEKA Srl

목차

제1장 조사 방법

제2장 주요 요약

• 시장 개요
• 주요 기업
• 시장 동향과 촉진요인
• 세계 시장 전망

제3장 시장 분석

• 미국
• 캐나다
• 일본
• 중국
• 유럽
• 프랑스
• 독일
• 이탈리아
• 영국
• 스페인
• 러시아
• 기타 유럽
• 아시아태평양
• 호주
• 인도
• 한국
• 기타 아시아태평양
• 라틴아메리카
• 아르헨티나
• 브라질
• 멕시코
• 기타 라틴아메리카
• 중동
• 이란
• 이스라엘
• 사우디아라비아
• 아랍에미리트(UAE)
• 기타 중동
• 아프리카

제4장 경쟁

영문목차

Global Central Venous Catheters (CVCs) Market to Reach US$2.0 Billion by 2030

The global market for Central Venous Catheters (CVCs) estimated at US$1.3 Billion in the year 2023, is expected to reach US$2.0 Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2023-2030. Multi-Lumen CVC, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$971.4 Million by the end of the analysis period. Growth in the Triple-Lumen CVC segment is estimated at 5.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$440.0 Million While China is Forecast to Grow at 7.7% CAGR

The Central Venous Catheters (CVCs) market in the U.S. is estimated at US$440.0 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$240.8 Million by the year 2030 trailing a CAGR of 7.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.0% and 5.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.5% CAGR.

Global Central Venous Catheters (CVCs) Market - Key Trends & Drivers Summarized

Central Venous Catheters (CVCs) are critical medical devices used for administering medication, fluids, blood products, and parenteral nutrition, as well as for hemodialysis and monitoring central venous pressure. These catheters are inserted into a large vein, typically in the neck (internal jugular vein), chest (subclavian vein), or groin (femoral vein), and threaded through to the central veins near the heart. CVCs are indispensable in the management of patients with severe illnesses, those undergoing major surgeries, and those requiring long-term intravenous therapy. They provide a reliable and long-term intravenous access point, crucial for the delivery of life-saving treatments and accurate hemodynamic assessment.

Advancements in CVC technology have led to significant improvements in their safety, efficacy, and ease of use. Modern CVCs are designed with features that minimize the risk of infection and mechanical complications. Antimicrobial-coated catheters, for instance, have been developed to reduce the incidence of catheter-related bloodstream infections (CRBSIs), a major concern in clinical practice. Additionally, advancements in catheter materials and insertion techniques have enhanced the durability and biocompatibility of CVCs. The use of ultrasound guidance for catheter placement has become standard practice, significantly reducing insertion-related complications and improving the success rate of the procedure. These technological and procedural innovations have made CVCs safer and more reliable for both patients and healthcare providers.

The growth in the central venous catheters market is driven by several factors, including the increasing prevalence of chronic diseases, advancements in medical technology, and the rising number of surgical procedures. The global rise in chronic conditions such as cancer, kidney disease, and heart failure has led to a higher demand for long-term intravenous therapies, consequently boosting the need for CVCs. Technological advancements have resulted in the development of more sophisticated and safer CVCs, which have enhanced their adoption in clinical settings. Furthermore, the growing number of surgical procedures and the expanding geriatric population, who are more likely to require intensive medical care, have further fueled market growth. The increasing focus on infection prevention and the development of antimicrobial and anti-thrombogenic coatings for CVCs are also contributing to the market's expansion. These factors, combined with ongoing research and development efforts to improve catheter design and functionality, are driving the robust growth of the central venous catheters market.

Select Competitors (Total 61 Featured) -

• GE Healthcare
• ConMed Corporation
• Edwards Lifesciences Corporation
• Biosensors International Group Ltd.
• ICU Medical, Inc.
• FUJIFILM SonoSite, Inc.
• Biometrix BV
• Bactiguard
• Global Medikit Ltd.
• Comed B.V.
• Foshan Special Medical Co., Ltd.
• Guangdong Baihe Medical Technology Co., Ltd.
• Biotronix Healthcare, Inc.
• Bionic Medizintechnik GmbH
• HEKA Srl

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Central Venous Catheters (CVCs) - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • Central Venous Catheter (CVC): An Indispensable Medical Device for Healthcare Domain
  • Contradictions & Complications of CVCs
  • Types of Central Venous Catheters
  • Global Market Prospects & Outlook
  • Global Central Venous Catheters Market by Product Type (in %) for 2020E
  • Multi-Lumen Design Leads the CVCs Market
  • Antimicrobial Coated Catheters to Witness High Growth
  • Hospitals: The Largest End-Use Category
  • Developing Economies to Spearhead Long-term Growth
  • Competition
  • World Brands
  • Recent Market Activity
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Chronic Diseases Necessitate Central Venous Access, Driving Demand for CVCs
  • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
  • World Diabetes and Population Statistics (2019, 2030 & 2045)
  • ESRD Prevalence Worldwide: Number of Treated ESRD Patients Per Million Population in Select Countries
  • Global Annual Medical Cost of CVD in US$ Billion: 2010, 2015, 2020, 2025 and 2030
  • Aging Population with Higher Susceptibility to Age-related Chronic Conditions to Drive Market Gains
  • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
  • Life Expectancy at Age 60 and 80 Years: (2010-2015), (2020-2025) & (2045-2050)
  • Use of Central Venous Catheterization for Chemotherapy Administration Boosts Market Growth
  • Catheters Hold Vital Role in Drugs & Fluid Delivery in Cancer Treatment
  • Expanding Patient Population Diagnosed with Renal Diseases: Potential Growth for CVCs Market
  • Global Dialysis Patient Population Breakdown by Geographic Region/Country (2019 and 2024)
  • Catheter-Related Infections during Hemodialysis Reduce due to Hygiene Procedures
  • Surgical Procedure Volumes and Shift towards Minimal Invasive Surgeries: Significant Impact on CVCs Market
  • Global Volume of Surgical Procedures (in Million) by Category
  • Growth in the Number of Surgeries in the US (2010-2020) and 2001-2010 (in %)
  • Number of Surgical Procedures (per 100,000 People) in Select Countries
  • Central Venous Catheters: Playing Critical Role in Parenteral Nutrition
  • Growing Role of Central Venous Catheters in Drug Administration
  • Rising Use of Central Venous Catheters in ICU Settings
  • Growing Adoption of Antimicrobial Impregnated Catheters
  • Technologically Advanced CVCs Promise Better Outcomes for Interventional Procedures
  • 3M Korea's All-in-One PICC/CVC Securing System
  • Clear Correlation between CVD Risk and Central Venous Catheter Insertion Calls for Minimization of Catheter Use
  • Consistent Rise in Healthcare Spending Worldwide to Drive Market Opportunities
  • World Healthcare Expenditure (In US$ Trillion) for the Years for 2017, 2019, 2021 and 2023
  • Elderly Healthcare Expenditure as a % of GDP in the US, Europe and Japan for 1970, 2010 and 2050
  • Challenges Facing Central Venous Catheters Market
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Central Venous Catheters (CVCs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 3: World 16-Year Perspective for Central Venous Catheters (CVCs) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Multi-Lumen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Multi-Lumen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 6: World 16-Year Perspective for Multi-Lumen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Triple-Lumen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Triple-Lumen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 9: World 16-Year Perspective for Triple-Lumen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Double-Lumen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Double-Lumen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 12: World 16-Year Perspective for Double-Lumen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 13: World Recent Past, Current & Future Analysis for Single-Lumen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 14: World Historic Review for Single-Lumen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 15: World 16-Year Perspective for Single-Lumen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Non-Antimicrobial Coated by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 17: World Historic Review for Non-Antimicrobial Coated by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 18: World 16-Year Perspective for Non-Antimicrobial Coated by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 19: World Recent Past, Current & Future Analysis for Antimicrobial Coated by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 20: World Historic Review for Antimicrobial Coated by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 21: World 16-Year Perspective for Antimicrobial Coated by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 22: World Recent Past, Current & Future Analysis for Jugular Vein by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 23: World Historic Review for Jugular Vein by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 24: World 16-Year Perspective for Jugular Vein by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 25: World Recent Past, Current & Future Analysis for Femoral Vein by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 26: World Historic Review for Femoral Vein by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 27: World 16-Year Perspective for Femoral Vein by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 28: World Recent Past, Current & Future Analysis for Subclavian Vein by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 29: World Historic Review for Subclavian Vein by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 30: World 16-Year Perspective for Subclavian Vein by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 31: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 32: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 33: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 34: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 35: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 36: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 37: World Central Venous Catheters (CVCs) Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 38: USA Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 40: USA 16-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2014, 2024 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 43: USA 16-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2014, 2024 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 46: USA 16-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2014, 2024 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 49: USA 16-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
• CANADA
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 52: Canada 16-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2014, 2024 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 55: Canada 16-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2014, 2024 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 58: Canada 16-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2014, 2024 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 61: Canada 16-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
• JAPAN
  • Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 64: Japan 16-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2014, 2024 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 67: Japan 16-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2014, 2024 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 70: Japan 16-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2014, 2024 & 2030
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 73: Japan 16-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
• CHINA
  • Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 74: China Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 76: China 16-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2014, 2024 & 2030
  • TABLE 77: China Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 79: China 16-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2014, 2024 & 2030
  • TABLE 80: China Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 82: China 16-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2014, 2024 & 2030
  • TABLE 83: China Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 84: China Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 85: China 16-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
• EUROPE
  • Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Central Venous Catheters (CVCs) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 88: Europe 16-Year Perspective for Central Venous Catheters (CVCs) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 91: Europe 16-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2014, 2024 & 2030
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 94: Europe 16-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2014, 2024 & 2030
  • TABLE 95: Europe Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 96: Europe Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 97: Europe 16-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2014, 2024 & 2030
  • TABLE 98: Europe Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 99: Europe Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 100: Europe 16-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
• FRANCE
  • Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 101: France Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 102: France Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 103: France 16-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2014, 2024 & 2030
  • TABLE 104: France Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 105: France Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 106: France 16-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2014, 2024 & 2030
  • TABLE 107: France Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 108: France Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 109: France 16-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2014, 2024 & 2030
  • TABLE 110: France Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 111: France Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 112: France 16-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
• GERMANY
  • Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 113: Germany Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 114: Germany Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 115: Germany 16-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2014, 2024 & 2030
  • TABLE 116: Germany Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 117: Germany Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 118: Germany 16-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2014, 2024 & 2030
  • TABLE 119: Germany Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 120: Germany Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 121: Germany 16-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2014, 2024 & 2030
  • TABLE 122: Germany Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 123: Germany Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 124: Germany 16-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
• ITALY
  • TABLE 125: Italy Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 126: Italy Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 127: Italy 16-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2014, 2024 & 2030
  • TABLE 128: Italy Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 129: Italy Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 130: Italy 16-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2014, 2024 & 2030
  • TABLE 131: Italy Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 132: Italy Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 133: Italy 16-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2014, 2024 & 2030
  • TABLE 134: Italy Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 135: Italy Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 136: Italy 16-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
• UNITED KINGDOM
  • Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 137: UK Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 138: UK Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 139: UK 16-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2014, 2024 & 2030
  • TABLE 140: UK Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 141: UK Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 142: UK 16-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2014, 2024 & 2030
  • TABLE 143: UK Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 144: UK Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 145: UK 16-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2014, 2024 & 2030
  • TABLE 146: UK Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 147: UK Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 148: UK 16-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
• SPAIN
  • TABLE 149: Spain Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 150: Spain Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 151: Spain 16-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2014, 2024 & 2030
  • TABLE 152: Spain Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 153: Spain Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 154: Spain 16-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2014, 2024 & 2030
  • TABLE 155: Spain Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 156: Spain Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 157: Spain 16-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2014, 2024 & 2030
  • TABLE 158: Spain Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 159: Spain Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 160: Spain 16-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
• RUSSIA
  • TABLE 161: Russia Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 162: Russia Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 163: Russia 16-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2014, 2024 & 2030
  • TABLE 164: Russia Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 165: Russia Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 166: Russia 16-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2014, 2024 & 2030
  • TABLE 167: Russia Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 168: Russia Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 169: Russia 16-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2014, 2024 & 2030
  • TABLE 170: Russia Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 171: Russia Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 172: Russia 16-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
• REST OF EUROPE
  • TABLE 173: Rest of Europe Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 174: Rest of Europe Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 175: Rest of Europe 16-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2014, 2024 & 2030
  • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 177: Rest of Europe Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 178: Rest of Europe 16-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2014, 2024 & 2030
  • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 180: Rest of Europe Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 181: Rest of Europe 16-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2014, 2024 & 2030
  • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 183: Rest of Europe Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 184: Rest of Europe 16-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
• ASIA-PACIFIC
  • Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 185: Asia-Pacific Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 186: Asia-Pacific Historic Review for Central Venous Catheters (CVCs) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 187: Asia-Pacific 16-Year Perspective for Central Venous Catheters (CVCs) by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 189: Asia-Pacific Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 190: Asia-Pacific 16-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2014, 2024 & 2030
  • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 192: Asia-Pacific Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 193: Asia-Pacific 16-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2014, 2024 & 2030
  • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 195: Asia-Pacific Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 196: Asia-Pacific 16-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2014, 2024 & 2030
  • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 198: Asia-Pacific Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 199: Asia-Pacific 16-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
• AUSTRALIA
  • Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
  • TABLE 200: Australia Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 201: Australia Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 202: Australia 16-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2014, 2024 & 2030
  • TABLE 203: Australia Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 204: Australia Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 205: Australia 16-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2014, 2024 & 2030
  • TABLE 206: Australia Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 207: Australia Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 208: Australia 16-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2014, 2024 & 2030
  • TABLE 209: Australia Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 210: Australia Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 211: Australia 16-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
• INDIA
  • Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
  • TABLE 212: India Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 213: India Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 214: India 16-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2014, 2024 & 2030
  • TABLE 215: India Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 216: India Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 217: India 16-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2014, 2024 & 2030
  • TABLE 218: India Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 219: India Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 220: India 16-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2014, 2024 & 2030
  • TABLE 221: India Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 222: India Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 223: India 16-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
• SOUTH KOREA
  • TABLE 224: South Korea Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 225: South Korea Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 226: South Korea 16-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2014, 2024 & 2030
  • TABLE 227: South Korea Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 228: South Korea Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 229: South Korea 16-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2014, 2024 & 2030
  • TABLE 230: South Korea Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 231: South Korea Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 232: South Korea 16-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2014, 2024 & 2030
  • TABLE 233: South Korea Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 234: South Korea Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 235: South Korea 16-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 236: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 237: Rest of Asia-Pacific Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 238: Rest of Asia-Pacific 16-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2014, 2024 & 2030
  • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 240: Rest of Asia-Pacific Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 241: Rest of Asia-Pacific 16-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2014, 2024 & 2030
  • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 243: Rest of Asia-Pacific Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 244: Rest of Asia-Pacific 16-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2014, 2024 & 2030
  • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 246: Rest of Asia-Pacific Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 247: Rest of Asia-Pacific 16-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
• LATIN AMERICA
  • Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
  • TABLE 248: Latin America Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 249: Latin America Historic Review for Central Venous Catheters (CVCs) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 250: Latin America 16-Year Perspective for Central Venous Catheters (CVCs) by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
  • TABLE 251: Latin America Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 252: Latin America Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 253: Latin America 16-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2014, 2024 & 2030
  • TABLE 254: Latin America Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 255: Latin America Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 256: Latin America 16-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2014, 2024 & 2030
  • TABLE 257: Latin America Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 258: Latin America Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 259: Latin America 16-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2014, 2024 & 2030
  • TABLE 260: Latin America Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 261: Latin America Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 262: Latin America 16-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
• ARGENTINA
  • TABLE 263: Argentina Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 264: Argentina Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 265: Argentina 16-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2014, 2024 & 2030
  • TABLE 266: Argentina Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 267: Argentina Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 268: Argentina 16-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2014, 2024 & 2030
  • TABLE 269: Argentina Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 270: Argentina Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 271: Argentina 16-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2014, 2024 & 2030
  • TABLE 272: Argentina Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 273: Argentina Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 274: Argentina 16-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
• BRAZIL
  • TABLE 275: Brazil Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 276: Brazil Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 277: Brazil 16-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2014, 2024 & 2030
  • TABLE 278: Brazil Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 279: Brazil Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 280: Brazil 16-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2014, 2024 & 2030
  • TABLE 281: Brazil Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 282: Brazil Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 283: Brazil 16-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2014, 2024 & 2030
  • TABLE 284: Brazil Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 285: Brazil Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 286: Brazil 16-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
• MEXICO
  • TABLE 287: Mexico Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 288: Mexico Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 289: Mexico 16-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2014, 2024 & 2030
  • TABLE 290: Mexico Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 291: Mexico Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 292: Mexico 16-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2014, 2024 & 2030
  • TABLE 293: Mexico Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 294: Mexico Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 295: Mexico 16-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2014, 2024 & 2030
  • TABLE 296: Mexico Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 297: Mexico Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 298: Mexico 16-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
• REST OF LATIN AMERICA
  • TABLE 299: Rest of Latin America Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 300: Rest of Latin America Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 301: Rest of Latin America 16-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2014, 2024 & 2030
  • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 303: Rest of Latin America Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 304: Rest of Latin America 16-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2014, 2024 & 2030
  • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 306: Rest of Latin America Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 307: Rest of Latin America 16-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2014, 2024 & 2030
  • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 309: Rest of Latin America Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 310: Rest of Latin America 16-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
• MIDDLE EAST
  • Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
  • TABLE 311: Middle East Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 312: Middle East Historic Review for Central Venous Catheters (CVCs) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 313: Middle East 16-Year Perspective for Central Venous Catheters (CVCs) by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
  • TABLE 314: Middle East Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 315: Middle East Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 316: Middle East 16-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2014, 2024 & 2030
  • TABLE 317: Middle East Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 318: Middle East Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 319: Middle East 16-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2014, 2024 & 2030
  • TABLE 320: Middle East Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 321: Middle East Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 322: Middle East 16-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2014, 2024 & 2030
  • TABLE 323: Middle East Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 324: Middle East Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 325: Middle East 16-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
• IRAN
  • TABLE 326: Iran Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 327: Iran Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 328: Iran 16-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2014, 2024 & 2030
  • TABLE 329: Iran Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 330: Iran Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 331: Iran 16-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2014, 2024 & 2030
  • TABLE 332: Iran Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 333: Iran Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 334: Iran 16-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2014, 2024 & 2030
  • TABLE 335: Iran Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 336: Iran Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 337: Iran 16-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
• ISRAEL
  • TABLE 338: Israel Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 339: Israel Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 340: Israel 16-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2014, 2024 & 2030
  • TABLE 341: Israel Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 342: Israel Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 343: Israel 16-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2014, 2024 & 2030
  • TABLE 344: Israel Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 345: Israel Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 346: Israel 16-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2014, 2024 & 2030
  • TABLE 347: Israel Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 348: Israel Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 349: Israel 16-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
• SAUDI ARABIA
  • TABLE 350: Saudi Arabia Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 351: Saudi Arabia Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 352: Saudi Arabia 16-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2014, 2024 & 2030
  • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 354: Saudi Arabia Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 355: Saudi Arabia 16-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2014, 2024 & 2030
  • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 357: Saudi Arabia Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 358: Saudi Arabia 16-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2014, 2024 & 2030
  • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 360: Saudi Arabia Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 361: Saudi Arabia 16-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
• UNITED ARAB EMIRATES
  • TABLE 362: UAE Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 363: UAE Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 364: UAE 16-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2014, 2024 & 2030
  • TABLE 365: UAE Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 366: UAE Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 367: UAE 16-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2014, 2024 & 2030
  • TABLE 368: UAE Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 369: UAE Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 370: UAE 16-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2014, 2024 & 2030
  • TABLE 371: UAE Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 372: UAE Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 373: UAE 16-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
• REST OF MIDDLE EAST
  • TABLE 374: Rest of Middle East Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 375: Rest of Middle East Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 376: Rest of Middle East 16-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2014, 2024 & 2030
  • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 378: Rest of Middle East Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 379: Rest of Middle East 16-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2014, 2024 & 2030
  • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 381: Rest of Middle East Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 382: Rest of Middle East 16-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2014, 2024 & 2030
  • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 384: Rest of Middle East Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 385: Rest of Middle East 16-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
• AFRICA
  • Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
  • TABLE 386: Africa Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 387: Africa Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 388: Africa 16-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2014, 2024 & 2030
  • TABLE 389: Africa Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 390: Africa Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 391: Africa 16-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2014, 2024 & 2030
  • TABLE 392: Africa Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 393: Africa Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 394: Africa 16-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2014, 2024 & 2030
  • TABLE 395: Africa Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 396: Africa Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 397: Africa 16-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION